These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6401436)

  • 1. Heavy chain loss after treatment with Melphalan in a patient with "nonsecretory" myeloma.
    Katagiri S; Yonezawa T; Kanayama Y; Tsubakio T; Tamaki T; Kanakura Y; Kurata Y; Tarui S
    Blut; 1983 Feb; 46(2):73-80. PubMed ID: 6401436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin production and secretion in Bence Jones protein myeloma and "nonsecretory" myeloma. Ultrastructural and immunofluorescence study.
    Yonezawa T; Kitani T; Tamaki T; Kanayama Y; Hiraoka A; Tarui S
    Blut; 1982 Aug; 45(2):121-9. PubMed ID: 7049267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light chain myeloma with features of the adult Fanconi syndrome: six years remission following one course of melphalan.
    von Schéele C
    Acta Med Scand; 1976; 199(6):533-7. PubMed ID: 820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural analysis of membrane-bound polysomes in mouse "nonsecretory" myeloma (nonproducing type).
    Yonezawa T; Kitani T; Yutoku M; Nishiuchi M; Hiraoka A; Tarui S
    Blut; 1983 Sep; 47(3):147-52. PubMed ID: 6882930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-secretory myeloma of heavy mu-chain type].
    Leglise MC; Briere J; Abgrall JF; Hurez D
    Nouv Rev Fr Hematol (1978); 1983; 25(2):103-6. PubMed ID: 6408608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma--complete remission with high dose melphalan chemotherapy.
    Richards F; Coleman M; Cooper MR; Ballard WP
    Cancer Invest; 1985; 3(1):15-21. PubMed ID: 3971199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma cells of the bone marrow in myelomatosis treated with Alkeran (melphalan).
    Axelsson U
    Scand J Haematol; 1966; 3(2):123-35. PubMed ID: 5946776
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.
    Preud'Homme JL; Morel-Maroger L; Brouet JC; Mihaesco E; Mery JP; Seligmann M
    Clin Exp Immunol; 1980 Dec; 42(3):545-53. PubMed ID: 6783355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease.
    Benjamin D; Joshua H; Djaldetti M; Hazaz B; Pinkhas J
    Scand J Haematol; 1979 Feb; 22(2):179-84. PubMed ID: 107577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Silent onset of multiple myeloma. How to diagnosis and when to treat?].
    Bartl R
    Internist (Berl); 1986 Mar; 27(3):192-200. PubMed ID: 3086250
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse of aggressive myeloma after complete remission in secondary acute leukemia: coincidence or consequence?
    Bairey OS; Sandbank Y; Shaklai M
    Leuk Lymphoma; 1993 Dec; 12(1-2):147-51. PubMed ID: 8161931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocythaemia and multiple myeloma. A report on two cases.
    Selroos O; van Assendelft A
    Acta Med Scand; 1977; 201(3):243-7. PubMed ID: 557871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Dunkley S; Gibson J; Iland H; Li C; Joshua D
    Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golenzer C; Adotti F; Dryll A; Roujeau J
    Pathol Eur; 1973; 8(4):287-98. PubMed ID: 4523953
    [No Abstract]   [Full Text] [Related]  

  • 20. Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma--a "France autogreffe" study.
    Colombat P; Milpied N; Laporte JP; Casassus P; Linassier C; Harousseu JL
    Cancer; 1994 Dec; 74(11):2930-4. PubMed ID: 7954256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.